Intravenous rt-PA for acute stroke: Comparing its effectiveness in younger and older patients

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 9, 2005, Pages 1234-1237

  Mouradian, M S ^b   Senthilselvan, A ^b   Jickling, G ^b   McCombe, J A ^b   Emery, D J ^b   Dean, N ^b   Shuaib, A ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARTHEL INDEX; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANKIN SCALE; STROKE;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 23944440095     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.047803     Document Type: Article

References (24)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study group. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 1995;333:1581-7.
2. Kwiatkowski TG, Libman R, Frankel M, for the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999;340:1781-7.
3. Wardlaw JM. Sandercock PAG. Berge E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke, where do we go from here? a cumulative meta-analysis. Stroke 2003;34:1437-42.
4. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28:2119-25.
5. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145-50.
6. Tanne D, Gorman MJ, Bates VE, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older. The tPA Stroke Survey experience. Stroke 2000;31:370-5.
7. Schlegel DJ, Tanne D, Demchuk AM, ef al. Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institute of Health Stroke Scale. Arch of Neurol 2004;61:1061-4.
8. Norris JW, Buchan A, Cote R, et al. on behalf of The Canadian Stroke Consortium. Canadian guidelines for intravenous thrombolytic treatment in acute stroke. Con J Neurol Sci 1998;25:257-9.
9. Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1996;27:1711-18.
10. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. Stroke 1994;25:2220-6.
11. van Swieten JC, Koudstaal PJ, Visser MC, et al. Inter-observer agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
12. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J 1965;14:61-5.
13. Hacke W, Kaste M, Fieschi C, et al. for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischeminc stroke (ECASS II). Lancet 1998;352:1245-51.
14. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-4.
15. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue. Asymptomatic or symptomatic? Stroke 2001;32:1330-5.
16. Frankel MR, Morgenstern LB, Kwiatkowski T, et al. For the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Predicting prognosis after stroke. A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke trial. Neurology 2000;55:952-9.
17. Chambers BR, Norris JW, Shurvell BL, et al. Prognosis of acute stroke. Neurology 1987;37:221-5.
18. Censori B, Camerlingo M, Casto L, et al. Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset. Stroke 1993;24:532-5.
19. Henon H, Godefroy O, Leys D, et al. Early predictors of death and disability after acute cerebral ischemic event. Stroke 1995;26:392-8.
20. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke. Predictors for death, and recurrent stroke within the first year. Stroke 2003;34:122-6.
21. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126-31.
22. Babikian VL, Caplan LR. Brain embolism is a dynamic process with variable characteristics. Neurology 2000;54:797-801.
23. Woo D, Broderick JP, Kothari RU, et al, for the NINDS t-PA Stroke Study Group. Does the National Institute of Health Stroke Scale favor left hemisphere strokes? Stroke 1999;30:2355-9.
24. Buchan AM, Barber PA, Newcommon N, et al. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology 2000;54:679-84.